Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Atkins

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Molecular Therapy. Nucleic Acids|August 21, 2020
Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding SitesCheng-Han Chung, Alexander G Allen, Andrew J Atkins, et al.
Chemical Communications (Cambridge, England)|May 9, 2015
Structural snapshots of the SCR reaction mechanism on Cu-SSZ-13Tobias Günter, Hudson W P Carvalho, Dmitry E Doronkin, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Molecular Therapy. Nucleic Acids|August 21, 2020
Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding SitesCheng-Han Chung, Alexander G Allen, Andrew J Atkins, et al.
Chemical Communications (Cambridge, England)|May 9, 2015
Structural snapshots of the SCR reaction mechanism on Cu-SSZ-13Tobias Günter, Hudson W P Carvalho, Dmitry E Doronkin, et al.
Pageof 2